5. Jeff Geschwind integrates metabolic tumor profiling with Cone Beam CT for enhanced TACE procedures in liver cancer. His work ensures accurate tumor localization, refined catheter placement, and better therapeutic distribution. This research supports the development of personalized embolization strategies that improve treatment success and patient quality of life. https://www.slideshare.net/slideshow/dr-jeff-geschwind-a-leading-innovator-in-oncology-and-interventional-radiology-docx/276648186